ownership in BNGO / BioNano Genomics Inc – 13F, 13D, 13G Filings – Fintel.io.
…
BlackRock Inc. ownership in BNGO / BioNano Genomics Inc.
| Security | BNGO / BioNano Genomics Inc |
|---|---|
| Institution | BlackRock Inc. |
| Latest Disclosed Ownership | 18,660,129 shares |
| Ownership | 6.50% |
Similarly How many shares are there of BNGO? BioNano Genomics Inc (US:BNGO) has 292 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 83,218,166 shares.
Does Ark hold BNGO? Does ARK Invest in BNGO: The Bottom Line. At this time, ARK does not invest in BNGO. With that said, the company does appear to have some promise in its own right. Like all speculative small-cap companies, Bionano Genomics is a risky stock to own.
Additionally, What is BNGO target price?
The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +258.85% increase from the last price of 2.09.
What institutions are buying NIO?
Largest shareholders include Baillie Gifford & Co, BlackRock Inc., Vanguard Group Inc, State Street Corp, VWIGX – Vanguard International Growth Fund Investor Shares, Susquehanna International Group, Llp, Goldman Sachs Group Inc, Citadel Advisors Llc, VEIEX – Vanguard Emerging Markets Stock Index Fund Investor Shares, …
How much cash does BNGO have? Bionano Genomics cash on hand from 2017 to 2021.
…
Compare BNGO With Other Stocks.
| Bionano Genomics Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2020 | $38 |
| 2019 | $17 |
| 2018 | $17 |
| 2017 | $1 |
What sector is BNGO stock in? Key Data
| Label | Value |
|---|---|
| Exchange | NASDAQ-CM |
| Sector | Capital Goods |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| 1 Year Target | $11.00 |
Is BNGO a pump and dump? BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.
What ETF holds BNGO?
ETF.com Insight
The largest ETF holder of BNGO is the iShares Russell 2000 ETF (IWM), with approximately 6.72M shares.
Is BNGO in ETF? Bionano Genomics is a life sciences instrumentation company in the genome analysis space.
…
| ETF | BNGO |
|---|---|
| Shares Out. | 289.61M |
| Market Cap. | 524.20M |
| Div/Shr | 0.00 |
| Div Yield | 0.00 |
Is BNGO a strong buy?
According to the issued ratings of 3 analysts in the last year, the consensus rating for Bionano Genomics stock is Buy based on the current 3 buy ratings for BNGO.
How high does IDEX go? IDEX stock hit a 2022 high of $1.44 in early January and a low of $0.87 later in the same month. In 2021 its stock price ranged from 88 cents to $5.53. In an interview with Capital.com, Vinod Jain, senior analyst at Aite-Novarica Group, said “the stock could see more volatility due to its current price point”.
Who owns the most stock in NIO?
Top 10 Owners of NIO Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 2.99% | 40,093,147 |
| The Vanguard Group, Inc. | 2.76% | 36,994,474 |
| SSgA Funds Management, Inc. | 2.45% | 32,887,731 |
| Goldman Sachs & Co. LLC (Private … | 1.73% | 23,202,778 |
What percent of Nio is public?
Public Company Ownership
Public companies currently own 8.5% of NIO stock. It’s hard to say for sure but this suggests they have entwined business interests. This might be a strategic stake, so it’s worth watching this space for changes in ownership.
Is BlackRock invested in NIO? 2022-02-10 – BlackRock Inc. has filed a 13F-HR form disclosing ownership of 64,036,975 shares of Nio Inc (US:NIO) with total holdings valued at $2,028,693,000 USD as of 2021-12-31.
What is the short interest on BNGO? Bionano Genomics currently has a short interest ratio of 5.0.
Who is shorting AMC?
Bank of America Is Shorting AMC Stock. Bank of America is on the list of the top 10 institutions shorting AMC stock. BofA is known for being an untrustworthy bank for the people, so it comes as no surprise.
What does Bionano genomics do? Bionano Genomics, Inc. provides a platform to analyze the long segments of genomic DNA and other biomolecules structural variations. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents.
What kind of company is Bionano genomics?
Bionano Genomics, Inc. provides a platform to analyze the long segments of genomic DNA and other biomolecules structural variations. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents.
Is BNGO in Russell? (Nasdaq: BNGO) announced today that it was added as a member of the US small-cap Russell 2000® Index, effective after the US market opens on Monday, June 28, 2021, as part of the 2021 Russell indexes reconstitution.
